Therapeutic potential of urine-derived stem cells in renal regeneration following acute kidney injury: A comparative analysis with mesenchymal stem cells

Figure 1 Experimental schedule. Experimental timeline illustrating the protocol for inducing acute kidney injury using glycerol, as well as the treatment regimen involving either urine-derived stem cells or bone marrow mesenchymal stem cells. At time 0, glycerol was administered intramuscularly. The arrow on day three indicates the administration of 500000 cells or vehicle alone. The following arrows indicate the designated time points for sacrificing the subjects. USCs: Urine-derived stem cells; BMSCs: Bone marrow mesenchymal stem cells.